|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US3832253A
(en)
|
1973-03-21 |
1974-08-27 |
Baxter Laboratories Inc |
Method of making an inflatable balloon catheter
|
|
US4450150A
(en)
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
DE2948884A1
(de)
|
1979-12-05 |
1981-06-11 |
Basf Ag, 6700 Ludwigshafen |
2-hydroxypropylimidazole, verfahren zu ihrer herstellung und verwendung als oelloesliche korrosionsinhibitoren
|
|
US4667014A
(en)
|
1983-03-07 |
1987-05-19 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4661450A
(en)
|
1983-05-03 |
1987-04-28 |
Molecular Genetics Research And Development Limited Partnership |
Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
|
|
CA1200416A
(en)
|
1983-05-13 |
1986-02-11 |
Societe Des Produits Nestle S.A. |
Food process
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
IN165717B
(https=)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
FR2645866B1
(fr)
|
1989-04-17 |
1991-07-05 |
Centre Nat Rech Scient |
Nouvelles lipopolyamines, leur preparation et leur emploi
|
|
JPH04167172A
(ja)
|
1990-10-31 |
1992-06-15 |
Nec Corp |
ベクトルプロセッサ
|
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
|
JPH07502898A
(ja)
|
1992-01-13 |
1995-03-30 |
デューク・ユニバーシティー |
酵素ｒｎａ分子
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
|
US5283241A
(en)
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
|
DK148292D0
(da)
|
1992-12-09 |
1992-12-09 |
Lundbeck & Co As H |
Forbindelser
|
|
US5591737A
(en)
|
1992-12-17 |
1997-01-07 |
Merck & Co., Inc. |
Substituted azetidinones as anti-inflammatory and antidegenerative agents
|
|
US6096880A
(en)
|
1993-04-15 |
2000-08-01 |
University Of Rochester |
Circular DNA vectors for synthesis of RNA and DNA
|
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
|
US5434261A
(en)
|
1993-07-26 |
1995-07-18 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
|
HUT75224A
(en)
|
1993-10-19 |
1997-04-28 |
Merck & Co Inc |
Combination of bisphosphonates and growth hormone secretagogues
|
|
AU686780B2
(en)
|
1994-03-11 |
1998-02-12 |
Merck & Co., Inc. |
Composition for the treatment of lung disease
|
|
CA2144940A1
(en)
|
1994-03-18 |
1995-09-19 |
Chikara Murakata |
Therapeutic agent for thrombocytopenia and indolocarbazole derivatives
|
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
|
US5656606A
(en)
|
1995-02-17 |
1997-08-12 |
Merck & Co., Inc. |
Camphor compounds promote release of growth hormone
|
|
US5747485A
(en)
|
1995-04-13 |
1998-05-05 |
Merck & Co., Inc. |
Substituted azetidiones as anti-inflammatory and antidegenerative agents
|
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
|
US5744335A
(en)
|
1995-09-19 |
1998-04-28 |
Mirus Corporation |
Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
|
|
GB2308064A
(en)
|
1995-10-31 |
1997-06-18 |
Merck & Co Inc |
Treatment of congestive heart failure with a growth hormone secretagogue
|
|
US5700549A
(en)
|
1996-06-24 |
1997-12-23 |
International Business Machines Corporation |
Structure to reduce stress in multilayer ceramic substrates
|
|
GB2324726A
(en)
|
1997-05-01 |
1998-11-04 |
Merck & Co Inc |
Combination Therapy for the Treatment of Osteoporosis
|
|
EP0897908A1
(de)
|
1997-08-19 |
1999-02-24 |
Roche Diagnostics GmbH |
3-Aryl-Succinamido-Hydroxamsäuren, Prozesse zu ihrer Herstellung und diese Substanzen enthaltende Medikamente
|
|
IL135578A0
(en)
|
1997-10-29 |
2001-05-20 |
Genzyme Corp |
Compositions and methods for treating lysosomal storage disease
|
|
US6211174B1
(en)
|
1997-10-31 |
2001-04-03 |
Merck & Co., Inc. |
Naphtho-fused lactams promote release of growth hormone
|
|
US5948902A
(en)
|
1997-11-20 |
1999-09-07 |
South Alabama Medical Science Foundation |
Antisense oligonucleotides to human serine/threonine protein phosphatase genes
|
|
WO1999035281A1
(en)
|
1998-01-09 |
1999-07-15 |
University Of Utah Research Foundation |
Method for in vitro amplification of circular dna
|
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
|
CA2400634A1
(en)
|
2000-02-17 |
2001-08-23 |
Chester Li |
Genetic modification of the lung as a portal for gene delivery
|
|
BRPI0109522B8
(pt)
|
2000-03-28 |
2017-04-11 |
Farm Bioindustries Pty Ltd |
construto genético linear e métodos para gerar planta transgênica ou progênie da mesma resistente a vírus ssdna e planta ou parte da mesma geneticamente modificada
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
US20040014194A1
(en)
|
2002-03-27 |
2004-01-22 |
Schering Corporation |
Beta-secretase crystals and methods for preparing and using the same
|
|
CN1882548A
(zh)
|
2003-10-24 |
2006-12-20 |
奥斯佩克斯制药公司 |
2,6－二异丙基苯酚的pH敏感性前药
|
|
WO2005079803A1
(en)
|
2004-02-13 |
2005-09-01 |
Pfizer Products, Inc. |
Compounds for treatment of cardiovascular diseases
|
|
US7799565B2
(en)
|
2004-06-07 |
2010-09-21 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering RNA
|
|
US7786153B2
(en)
|
2005-03-02 |
2010-08-31 |
Abbott Laboratories Inc. |
Compounds that are useful for improving pharmacokinetics
|
|
US9006487B2
(en)
|
2005-06-15 |
2015-04-14 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
WO2007044627A2
(en)
|
2005-10-06 |
2007-04-19 |
Sloan Kettering Institute For Cancer Research |
Compositions and methods for delivery of interfering rna
|
|
CN101016264A
(zh)
|
2007-01-22 |
2007-08-15 |
西安新安医药科技有限公司 |
用于治疗的硝基咪唑衍生物、制备方法及用途
|
|
US20100015218A1
(en)
|
2007-02-16 |
2010-01-21 |
Vasant Jadhav |
Compositions and methods for potentiated activity of biologically active molecules
|
|
JP5296328B2
(ja)
|
2007-05-09 |
2013-09-25 |
独立行政法人理化学研究所 |
１本鎖環状ｒｎａおよびその製造方法
|
|
US8283344B2
(en)
|
2007-09-10 |
2012-10-09 |
Merck & Co., Inc. |
Method of treating inherited severe neutropenia
|
|
CN104119242B
(zh)
|
2008-10-09 |
2017-07-07 |
泰米拉制药公司 |
改善的氨基脂质和递送核酸的方法
|
|
ES2646630T3
(es)
|
2008-11-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Lipidoides aminoalcohólicos y usos de los mismos
|
|
WO2010084371A1
(en)
|
2009-01-26 |
2010-07-29 |
Mitoprod |
Novel circular interfering rna molecules
|
|
US20100305197A1
(en)
|
2009-02-05 |
2010-12-02 |
Massachusetts Institute Of Technology |
Conditionally Active Ribozymes And Uses Thereof
|
|
US20120202801A1
(en)
|
2009-05-27 |
2012-08-09 |
Liangxian Cao |
Methods for treating breast cancer
|
|
US20120157402A1
(en)
|
2009-05-27 |
2012-06-21 |
Liangxian Cao |
Methods for treating brain tumors
|
|
US8697662B2
(en)
|
2009-05-27 |
2014-04-15 |
Ptc Therapeutics, Inc. |
Methods for treating Kaposi sarcoma
|
|
MX373926B
(es)
|
2009-05-27 |
2020-07-10 |
Ptc Therapeutics Inc |
Metodos para tratar cancer y estados no neoplasicos.
|
|
US20120157401A1
(en)
|
2009-05-27 |
2012-06-21 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
WO2010138685A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
MX342785B
(es)
|
2009-06-10 |
2016-10-12 |
Alnylam Pharmaceuticals Inc |
Formulacion mejorada de lipido.
|
|
JP5267874B2
(ja)
|
2009-07-24 |
2013-08-21 |
ソニー株式会社 |
信号処理装置、及び、信号処理方法
|
|
KR20110095439A
(ko)
|
2010-02-19 |
2011-08-25 |
건국대학교 산학협력단 |
암모니움 이미다졸륨 염 및 이를 함유하는 염료감응 태양전지용 전해질 조성물
|
|
EP2558074B1
(en)
|
2010-04-08 |
2018-06-06 |
The Trustees of Princeton University |
Preparation of lipid nanoparticles
|
|
CA2824526C
(en)
|
2011-01-11 |
2020-07-07 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
|
PL3586861T3
(pl)
|
2011-06-08 |
2022-05-23 |
Translate Bio, Inc. |
Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna
|
|
EP3354644A1
(en)
|
2011-06-08 |
2018-08-01 |
Translate Bio, Inc. |
Cleavable lipids
|
|
JP6018197B2
(ja)
|
2011-07-21 |
2016-11-02 |
クローダ インターナショナル パブリック リミティド カンパニー |
分枝状ポリエーテル−ポリアミドブロックコポリマー並びにそれらの製造方法及び使用方法
|
|
JP6093710B2
(ja)
|
2011-11-18 |
2017-03-08 |
日油株式会社 |
細胞内動態を改善したカチオン性脂質
|
|
GB2496898B
(en)
|
2011-11-25 |
2020-10-28 |
Petroliam Nasional Berhad Petronas |
Corrosion inhibition
|
|
JP6284181B2
(ja)
|
2012-02-09 |
2018-02-28 |
国立研究開発法人理化学研究所 |
環状ｒｎａ及びタンパク質の製造方法
|
|
EP4331620A3
(en)
*
|
2012-12-07 |
2024-12-04 |
Translate Bio, Inc. |
Lipidic nanoparticles for mrna delivery
|
|
WO2014134445A1
(en)
|
2013-02-28 |
2014-09-04 |
Tufts Unversity |
Disulfide compounds for delivery of pharmaceutical agents
|
|
PL2968440T3
(pl)
|
2013-03-15 |
2019-12-31 |
Zymeworks Inc. |
Związki cytotoksyczne i antymitotyczne oraz sposoby ich stosowania
|
|
ES2746803T3
(es)
|
2013-05-15 |
2020-03-06 |
Robert Kruse |
Traducción intracelular de ARN circular
|
|
EP3017013A4
(en)
|
2013-05-28 |
2017-01-25 |
Yanjie Xu |
Refrigeration system with dual refrigerants and liquid working fluids
|
|
US8805972B1
(en)
|
2013-06-26 |
2014-08-12 |
Kaspersky Lab Zao |
Multi-platform operational objective configurator for computing devices
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
ES2895651T3
(es)
|
2013-12-19 |
2022-02-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para la administración de agentes activos
|
|
US10821175B2
(en)
|
2014-02-25 |
2020-11-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
SG10201912038TA
(en)
|
2014-04-23 |
2020-02-27 |
Modernatx Inc |
Nucleic acid vaccines
|
|
US10407683B2
(en)
|
2014-07-16 |
2019-09-10 |
Modernatx, Inc. |
Circular polynucleotides
|
|
CA2955569C
(en)
|
2014-08-06 |
2023-02-14 |
Ascendis Pharma A/S |
Prodrugs comprising an aminoalkyl glycine linker
|
|
EP4219532A3
(en)
*
|
2015-06-05 |
2023-08-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for transient gene therapy with enhanced stability
|
|
WO2017009376A1
(en)
|
2015-07-13 |
2017-01-19 |
Curevac Ag |
Method of producing rna from circular dna and corresponding template dna
|
|
WO2017027291A1
(en)
|
2015-08-07 |
2017-02-16 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Bispecific car t-cells for solid tumor targeting
|
|
HK1256704A1
(zh)
|
2015-08-21 |
2019-10-04 |
辉瑞公司 |
包含治疗剂的治疗性纳米粒及其制备和使用方法
|
|
JP6685039B2
(ja)
|
2015-08-26 |
2020-04-22 |
国立大学法人東北大学 |
化合物、イオン液体、白金族元素の抽出剤、白金族元素の抽出方法
|
|
LU92830B1
(en)
|
2015-09-15 |
2017-04-03 |
Luxembourg Inst Of Health Lih |
Biomarkers for heart failure
|
|
CN105176981B
(zh)
|
2015-09-17 |
2017-03-15 |
广州永诺健康科技有限公司 |
用于环状rna表达的dna序列和表达载体及其应用
|
|
EP4286012A3
(en)
|
2015-09-17 |
2024-05-29 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
EP3356556B1
(en)
|
2015-09-29 |
2019-12-11 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
A method for diagnosing a disease by detection of circrna in bodily fluids
|
|
HK1258570A1
(zh)
|
2015-09-30 |
2019-11-15 |
Vertex Pharmaceuticals Inc. |
使用dna损伤剂及atr抑制剂的组合治疗癌症的方法
|
|
TW201729835A
(zh)
|
2015-10-22 |
2017-09-01 |
現代公司 |
呼吸道病毒疫苗
|
|
IL307179A
(en)
|
2015-10-28 |
2023-11-01 |
Acuitas Therapeutics Inc |
Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
AU2017205101B2
(en)
|
2016-01-08 |
2023-05-04 |
Breast Cancer Now |
Inhibitors of ataxia-telangiectasia mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer
|
|
EP3458106A4
(en)
|
2016-05-18 |
2020-03-18 |
Modernatx, Inc. |
POLYNUCLEOTIDS FOR CODING LIPOPROTEIN LIPASE FOR TREATING HYPERLIPIDEMIA
|
|
MA45036A
(fr)
|
2016-05-18 |
2019-03-27 |
Modernatx Inc |
Polynucléotides codant pour la citrine pour le traitement de la citrullinémie de type 2
|
|
EP3458104A1
(en)
|
2016-05-18 |
2019-03-27 |
Modernatx, Inc. |
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
|
|
US20190298657A1
(en)
|
2016-05-18 |
2019-10-03 |
Modernatx, Inc. |
Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
|
|
MA45052A
(fr)
|
2016-05-18 |
2019-03-27 |
Modernatx Inc |
Polynucléotides codant pour jagged1 pour le traitement du syndrome d'alagille
|
|
KR102469450B1
(ko)
|
2016-05-18 |
2022-11-22 |
모더나티엑스, 인크. |
인터류킨-12 (il12)를 코딩하는 폴리뉴클레오티드 및 그의 용도
|
|
KR20230074598A
(ko)
|
2016-05-18 |
2023-05-30 |
모더나티엑스, 인크. |
릴랙신을 인코딩하는 폴리뉴클레오타이드
|
|
WO2017201348A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1
|
|
EP3472193A4
(en)
|
2016-06-20 |
2020-01-08 |
The Board of Trustees of the Leland Stanford Junior University |
CIRCULAR RNA AND THEIR USE IN IMMUNOMODULATION
|
|
US20180010175A1
(en)
|
2016-09-22 |
2018-01-11 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for cloning circular rna
|
|
SG11201903674YA
(en)
|
2016-10-26 |
2019-05-30 |
Modernatx Inc |
Messenger ribonucleic acids for enhancing immune responses and methods of use thereof
|
|
BR112019008481A2
(pt)
*
|
2016-10-26 |
2020-03-03 |
Curevac Ag |
Vacinas de mrna de nanopartículas lipídicas
|
|
US20190290694A1
(en)
|
2016-12-21 |
2019-09-26 |
Cellectis |
Stably enginereed proteasome inhibitor resistant immune cells for immunotherapy
|
|
EP3564375A4
(en)
|
2016-12-27 |
2020-12-16 |
The University Of Tokyo |
ARNM FUNCTIONALIZATION PROCESS
|
|
JP2020514321A
(ja)
|
2017-02-01 |
2020-05-21 |
モデルナティーエックス， インコーポレイテッド |
活性化がん遺伝子変異ペプチドをコードする免疫調節治療ｍＲＮＡ組成物
|
|
CN106801050B
(zh)
|
2017-02-20 |
2020-01-14 |
广州永诺生物科技有限公司 |
一种环状rna高通量测序文库的构建方法及其试剂盒
|
|
US20200368162A1
(en)
|
2017-02-24 |
2020-11-26 |
Modernatx, Inc. |
Nucleic Acid-Based Therapy of Muscular Dystrophies
|
|
EP3595713A4
(en)
|
2017-03-15 |
2021-01-13 |
ModernaTX, Inc. |
RESPIRATORY SYNCYTIAL VIRUS Vaccine
|
|
SMT202300097T1
(it)
|
2017-03-15 |
2023-05-12 |
Modernatx Inc |
Composto e composizioni per il rilascio intracellulare di agenti terapeutici
|
|
US11753434B2
(en)
*
|
2017-04-14 |
2023-09-12 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for transient gene therapy with enhanced stability
|
|
EP3630966B1
(en)
|
2017-05-31 |
2025-04-23 |
Vilnius University |
Production of cyclic adenylates and their use as allosteric regulators
|
|
US11756183B2
(en)
|
2017-06-23 |
2023-09-12 |
Cornell University |
RNA molecules, methods of producing circular RNA, and treatment methods
|
|
CA3080592A1
(en)
*
|
2017-10-31 |
2019-05-09 |
Modernatx, Inc. |
Lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide
|
|
IL316195A
(en)
*
|
2017-12-15 |
2024-12-01 |
Flagship Pioneering Innovations Vi Llc |
Preparations containing circular polyribonucleotides and uses thereof
|
|
JP2021512090A
(ja)
|
2018-01-30 |
2021-05-13 |
モデルナティーエックス， インコーポレイテッド |
免疫細胞に薬剤を送達するための組成物及び方法
|
|
JP2021523110A
(ja)
*
|
2018-05-01 |
2021-09-02 |
フレッド ハッチンソン キャンサー リサーチ センター |
遺伝子発現のためのナノ粒子及びその使用
|
|
WO2019222275A2
(en)
*
|
2018-05-14 |
2019-11-21 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using inducible fusion proteins
|
|
CA3100276A1
(en)
|
2018-06-06 |
2019-12-12 |
Massachusetts Institute Of Technology |
Circular rna for translation in eukaryotic cells
|
|
WO2020010242A1
(en)
|
2018-07-03 |
2020-01-09 |
Washington State University |
Pharmaceutical agents for use in smoking and tobacco cessation
|
|
CA3107456A1
(en)
|
2018-07-24 |
2020-01-30 |
Mayo Foundation For Medical Education And Research |
Circularized engineered rna and methods
|
|
JP7283669B2
(ja)
|
2018-08-17 |
2023-05-30 |
チャンチョウ ピエン ツェ フアン ファーマシューティカル カンパニー リミテッド |
３－アリールオキシ－３－アリール－プロピルアミン化合物およびその用途
|
|
US12263248B2
(en)
|
2018-09-19 |
2025-04-01 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN113661242A
(zh)
|
2019-03-25 |
2021-11-16 |
旗舰创业创新第六有限责任公司 |
包含经修饰的环状多核糖核苷酸的组合物及其用途
|
|
WO2020237227A1
(en)
|
2019-05-22 |
2020-11-26 |
Massachusetts Institute Of Technology |
Circular rna compositions and methods
|
|
CN114007655A
(zh)
|
2019-06-14 |
2022-02-01 |
旗舰创业创新第六有限责任公司 |
用于细胞疗法的环状rna
|
|
EP4022069A4
(en)
|
2019-08-28 |
2023-12-20 |
The Board of Trustees of the Leland Stanford Junior University |
MODIFIED CIRCULAR RNAS AND METHOD OF USE THEREOF
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2021055849A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
EP3819377A1
(en)
|
2019-11-08 |
2021-05-12 |
Justus-Liebig-Universität Gießen |
Circular rna and uses thereof for inhibiting rna-binding proteins
|
|
AU2020397956A1
(en)
|
2019-12-04 |
2022-07-07 |
Orna Therapeutics, Inc. |
Circular RNA compositions and methods
|